WO2024256494A1 - Angled fiber-based neural implant for neuromodulation - Google Patents
Angled fiber-based neural implant for neuromodulation Download PDFInfo
- Publication number
- WO2024256494A1 WO2024256494A1 PCT/EP2024/066284 EP2024066284W WO2024256494A1 WO 2024256494 A1 WO2024256494 A1 WO 2024256494A1 EP 2024066284 W EP2024066284 W EP 2024066284W WO 2024256494 A1 WO2024256494 A1 WO 2024256494A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fiber
- core
- shank
- cladding
- conduits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N2005/0612—Apparatus for use inside the body using probes penetrating tissue; interstitial probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0632—Constructional aspects of the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Definitions
- the present invention relates to an angled optical fiber-based neural implant for neuromodulation of different brain regions and a method for manufacturing such neural implant.
- An optical fiber-based neural implant is an optoelectronic device used in neuroscience and medical applications to study and manipulate the activity of neurons in the central and peripheral nervous systems. It is a tiny implantable device made up of a thin fiber optic cable, which is typically coated with a polymer material, such as silicone or polyimide, to prevent damage to surrounding brain tissue.
- a polymer material such as silicone or polyimide
- the implant is designed to be inserted into a brain or other neural tissue and can record electrical signals from individual or populations of neurons, provide optical stimulation to manipulate neuron activity, or deliver drugs to specific regions of the brain.
- Fiber-based neural implants are often used in deep-brain stimulation, a therapy used to treat conditions such as Parkinson's disease, chronic pain, and epilepsy.
- neural implants provide researchers with the means to modulate and decode neural activity at a local level.
- Optogenetics With neural implants marks a milestone in the field of implantable neural interfaces. Optogenetics leverages light-sensitive proteins to selectively control and monitor neural activity with precision. By incorporating optogenetics into implantable devices, researchers can achieve bidirectional neural interfacing, facilitating real-time communication between neural circuits and external control systems. This capability opens up new avenues for investigating complex brain dynamics and developing advanced therapeutic interventions.
- a second optical modality is infrared neuromodulation.
- Infrared neuromodulation uses infrared light to manipulate neural activity in the central or peripheral nervous system. This method does not require virus and genetic modification. Infrared light is absorbed by the tissue without causing damage, interacting with molecules in the cells to trigger physiological responses. This can be achieved through photo thermal effects, optogenetics with infrared-sensitive opsins, or temperature-sensitive ion channels.
- implantable neural interfaces utilizing electrophysical signals and using optogenetics and infrared neuromodulation extends beyond the realm of scientific research. These devices hold promise in the treatment of neurological diseases, providing innovative approaches to address conditions that were once deemed untreatable.
- implantable neural interfaces enable targeted interventions and personalized therapies. From neurodegenerative disorders to psychiatric conditions and epilepsy, these devices are transforming our ability to manage and improve the lives of individuals affected by neurological diseases.
- Fiber-based neural implants have been proven to be effective in providing deepbrain neuromodulation. These implants are now integrated with multi-functional microstructures that allow for optical stimulation, electric signal recording, and drug delivery all at the same time.
- the device's output is limited to a flat fiber end, which means that the interface can only probe a specific location/depth within the brain. In other words, the device can only interact with a small area of the brain, which limits its overall efficacy. While the integrated microstructures allow for multiple functionalities, the design of the device remains a barrier to a more comprehensive and effective neuromodulation across different brain and/or neural regions.
- an improved fiber-based implantable neural implant for deep-brain neuromodulation would be advantageous, and in particular a more efficient and/or reliable neural implant for deep-brain neuromodulation at different depths into the brain would be advantageous.
- the above described object and several other objects are intended to be obtained in a first aspect of the invention by providing an angled fiber-based neural implant for neuromodulation in tissue, wherein the neural implant comprises o a fiber shank, and o an adaptor, for setup connectorization and light source connectorization,
- the fiber shank comprises o a proximal end connected to the adaptor, o an implanted end for implantation into tissue, and o a fiber tip at the implanted end, o an optical waveguide for optical neuromodulation, o a plurality of conduits, and o electrodes may be inserted into one, or more, of the plurality of conduits for electrical neuromodulation,
- the optical waveguide comprises a core and a cladding, adapted so that light is able to propagate along the length of the waveguide,
- the cladding comprises a central hole, the core is placed in the central hole and is going from the proximal end to the fiber tip, and
- the plurality of conduits are embedded in the fiber shank, each conduit going from the proximal end to the fiber tip; wherein the non-circular shape of the core is arranged for providing a substantially uniform intensity distribution of light radiation from the core at the fiber tip; and wherein the fiber tip comprises an angled surface, the end of the core and the end of the plurality of conduits are exposed at the angled surface, so that the plurality of conduits emanates at two, or more, different levels, where each level comprises a different depth into the tissue.
- the invention relates to an optical fiber-based neural implant with an angled tip.
- Fiber-based neural implants are effective devices for deep-brain neuromodulation.
- Integrated multi-functional microstructures can provide optical stimulation, electric signal recording, imaging and drug delivery at the same time.
- all the output conduits of the device end at a flat fiber end, and therefore can only achieve interrogate at one specific location/depth in the tissue, which may be brain tissue.
- the invention presents a new structure by controllably angling the tip of the fiber neural device with integrated functional microstructure conduits the longitudinal length of the fiber direction.
- the tip of the fiber comprises an angle that is introduced either by the mechanic cutting or grinding method in a controllable way.
- All the functional microstructures including but not limited to the electrodes and microfluidic channels, are placed along the length of the fiber.
- the depth between each microstructure can be adjusted by the diameter of the fiber shank and the angle at the tip of the fiber. In this way, depth-resolved neural activity recording or chemical stimulation can be achieved.
- most delivered power is located at the center of the fiber core since the light guided by optical fiber has a Gaussian profile. The result being that the depth-resolved implant having different optical stimulation efficiency at different depths in the tissue.
- the light profile at the output end of a 30° tip angle fiber has a very uneven/non-uniform distribution.
- the shape of the fiber core used is square. The square core would make the guided light modes mix and form an extremely even light distribution at the implanted end of the fiber as seen in figure 4b.
- Fiber-based neural implants have the advantage of low production costs and high reliability.
- all the electrodes emanate at the flat end surface of the fiber shank. This makes the implant activate or record from the neurons at one specific cortical layer in the brain.
- longitudinal distributed electrodes have to be added by some very complicated methods, such as micro-fabrication, and photolithography. This lead to a high development production cost.
- the longitudinal distributed electrodes are introduced to the angled fiber tip with a blade cutting or fiber polishing method providing a fiber shank having a depth-resolved neural recording function with a very low fabrication cost.
- the existing implantable fiber-based neural implants have a round core shape and an uneven light distribution at the output end of the optical waveguide.
- the proposed fiber implant has a square core shape, which can make the guiding mode mix and form a uniform emission pattern.
- the core may be formed as a square, a rectangle, quadrangle, or any non-circular form from which a substantially uniform intensity distribution of light radiation from the core is obtained.
- the setup connectorization may comprise an electrophysiology setup connectorization or a photopharmacology setup connectorization or an optical setup.
- Neuromodulation refers to the process of using various techniques to modify or regulate the activity of the nervous system. It involves the application of electrical, chemical, or physical stimulation to specific neural structures in order to modulate their function.
- Neuromodulation techniques are primarily used for therapeutic purposes to treat neurological and psychiatric conditions that involve abnormal neural activity.
- Electrophysiology is a branch of physiology that studies the electrical activity of biological cells and tissues. It involves the measurement and analysis of electrical signals generated by living organisms, particularly the electrical properties of cells, such as neurons and muscle cells.
- Photopharmacology is a field of research that involves the development and use of photosensitive molecules - photopharmaceuticals - to control biological processes with light. It combines principles from pharmacology and optics to enable precise spatiotemporal control over cellular processes and signalling pathways.
- Photopharmacology relies on the use of drugs that interact with specific molecular targets in the body, such as receptors or enzymes, to modulate their activity and produce a desired effect.
- photosensitive molecules are designed to undergo specific chemical or structural changes upon exposure to light, allowing them to switch their activity on or off in a controlled manner.
- the fiber-based implantable neural implant comprises several components, including:
- Fiber shank This is the main body of the implant housing the optical waveguide and any associated electronics or sensors.
- the fiber shank may be 10 cm long when used in humans but may also be as small as 1-4 mm for instance when used in small animals.
- the diameter of the fiber shank may be 0.1 - 1 mm.
- the optical waveguide transmits light and comprises a core and a cladding.
- the optical waveguide is substantially identical to the fiber shank with the exception of additions of conduits and electrodes to the fiber shank.
- the core is an optical material that is designed to transmit light signals. It can be used to both stimulate and monitor neural activity.
- the core is made of material of a different refractive index than the cladding. Typically, the refractive index of the core is higher than the refractive index of the cladding, but the refractive index of the core may alternatively be lower than the refractive index of the cladding through bandgap/antiresonant mechanism, the core and cladding are constructed so that the transmitted light substantially propagates in the core.
- the core When the refractive index of the core is higher than the refractive index of the cladding, the core may be made of polycarbonate with a refractive index of 1.57 while the cladding may by made of poly methyl methacrylate with a refractive index of 1.48. In the case when the refractive index of the core is lower than the refractive index of the cladding, the core may be air with a refractive index of 1.00.
- the cladding houses the core which is placed in a central hole in the cladding and the conduits which are electrodes, microfluidic channels, and other possible sensors.
- the cladding may be made from a variety of materials, such as, glass, polymers, or a combination hereof.
- the cladding will typically have the form of a tube.
- the conduits are channels going from the proximal end of the fiber shank to the inserted end, where they emanate in the angled surface.
- the conduits are holding electrodes to measure electrical neuronal activities at the outlet end of the conduit, or the conduits may be used as channels for delivering drugs.
- Electrodes are small conductive elements that are used to detect or stimulate electrical activity in the brain. They are integrated into microstructure conduits in the cladding and may be used in conjunction with the optical core to provide a more complete picture of neural activity.
- the implant may also include various types of sensors, such as temperature sensors, pressure sensors, or chemical sensors. These sensors can be used to monitor changes in the environment surrounding the implant, providing additional context for the neural activity being recorded.
- sensors such as temperature sensors, pressure sensors, or chemical sensors. These sensors can be used to monitor changes in the environment surrounding the implant, providing additional context for the neural activity being recorded.
- the neural implant may include various types of electronics, such as amplifiers or signal processors, which are used to amplify and analyse the signals collected by the optical fibers, electrodes, and microfluidic channels.
- electronics such as amplifiers or signal processors, which are used to amplify and analyse the signals collected by the optical fibers, electrodes, and microfluidic channels.
- the proximal end of the fiber shank is connected to an adaptor.
- the adaptor may be connected to external equipment, such as data acquisition systems or stimulation devices.
- the adaptor may be connected to a light source, so that the adapter ensures the light is transmitted into the core of the optical waveguide.
- the adaptor may also be connected to the microfluidic channels ensuring that drugs are delivered into the microfluidic channels.
- the angled surface of the fiber tip comprises an angle relative to the longitudinal direction of the fiber shank so that the angled surface is not perpendicular relative to the longitudinal direction of the fiber shank.
- the angle of the fiber tip relative to the longitudinal direction of the fiber shank is between 0° and 90° degrees, more preferable between 15° and 75°, or even more preferable between 30° and 60°.
- the angle may preferably be 30° ensuring that the channels emanate at different depths in the tissue.
- the angle may be selected to ensure the different depths are suitable for the task to be performed.
- the cross-section of the core is substantially formed as a rectangle, a square, or any non-circular geometry.
- the cross-section of the core is formed as a square, but other forms may also be used.
- the cross-section may be a rectangle, a quadrangle, or any other form providing a substantially uniform intensity distribution of light radiation from the core at the fiber tip. That the core is substantially formed as a square or a rectangle is to be understood that the square or rectangle may have rounded corners.
- the cladding surrounds the core so that the optical waveguide and electrodes in the fiber tip are in contact with tissue when implanted.
- the fiber shank is formed so the core is inside the cladding, so the only part of the core in contact with the tissue when implanted is exposed at the angled surface end.
- the cladding comprises microfluidic channels for drug delivery in photopharmacology.
- the microfluidic channels are conduits wherein no electrode is inserted, or from which an electrode has been removed.
- the core and the cladding are made of polymer materials with a Young's modulus less than 10 GPa.
- the cladding may be made of polymer and the core may be made of glass.
- the neural implant is inserted in neural tissue and therefore the implant may preferably be made of soft material to reduce possible damage to the neural tissue.
- the proximal end is attached to the adaptor, and by connecting the adaptor with a light source, light is delivered to the fiber tip.
- the electrodes are exposed at the proximal end for the connectorization with an electrophysiology setup for neural activity recording.
- the invention in a second aspect, relates to a method for manufacturing an angled fiber-based neural implant for neuromodulation in tissue, wherein the neural implant comprises o a fiber shank, and o an adaptor, for setup connectorization and light source connectorization,
- the fiber shank comprises o a proximal end connected to the adaptor, o an implanted end for implantation into tissue, o a fiber tip at the implanted end, o an optical waveguide for optical neuromodulation;
- the optical waveguide comprises a core and a cladding, adapted so that light is able to propagate along the length of the waveguide
- the method comprises: providing core material for the core of the optical waveguide, providing cladding material for the cladding of the optical waveguide, - forming a preform comprising the core material and the cladding material so that the core material is inserted into the cladding material, so that a structure is formed in a preform
- the method is performed so that the fiber shank comprises an optical waveguide, the optical waveguide comprises
- a core comprising a non-circular shape for providing a substantially uniform intensity distribution of light radiation from the core at the fiber tip of the fiber shank when guiding light from a light source at the proximal end
- cladding comprising a central hole, for holding the core, and a plurality of conduits
- electrodes may be inserted into one, or more, of the plurality of conduits for electrical neuromodulation
- the optical waveguide is manufactured so that light is able to propagate in the core of the optical waveguide by the total internal reflection principle.
- This aspect of the invention is particularly, but not exclusively, advantageous in that the method according to the present invention may be used to manufacture a neural implant with a core comprising a non-circular shape for providing a substantially uniform intensity distribution of light radiation from the core at the fiber tip of the fiber shank and further by providing a fiber tip with an angled surface, the surface being angled relative to the longitudinal direction of the fiber shank, hereby providing conduits emanating at different depth in the tissue when implanted.
- the method further comprises introducing electrodes by either - a modified thermal drawing method, namely, loading electrodes into the conduits in the cladding during the drawing process, or
- a post-insertion method comprising exposing the conduits in the cladding followed by the insertion of the electrodes.
- the method further comprises adjusting the fiber tip of the fiber shank by mechanical cutting, focused ion beam cutting, chemical etching, and/or femtosecond laser micromachining of the fiber tip, so that the plurality of conduits emanates at two, or more, different levels, where each level comprises a different depth into the tissue.
- the fiber tip may be adjusted by many different methods, it may be by mechanical cutting, focused ion beam cutting, chemical etching, and/or femtosecond laser micromachining, but any other method to form an angled surface with outlets for the core and the conduits may be used.
- the method further comprises adjusting the fiber tip at an angle between an angled surface of the fiber tip relative to the longitudinal direction of the fiber shank between 0° and 90° degrees, more preferably between 15° and 75°, or even more preferable between 30° and 60°.
- the method further comprises
- Fig. 1 illustrates the fiber shank of the neural implant.
- Fig. 2 illustrates the side view of the fiber implant with microstructure conduits illustrated in dashed lines for neuromodulation at different depths.
- Fig. 3 illustrates the neural implant inserted in a brain of a mouse.
- Fig. 4a and 4b illustrate the difference between using a circular or a square core in the fiber shank.
- Fig. 5a and 5b illustrate a method for manufacturing the fiber shank for the neural implant.
- Fig. 6a and 6b illustrate two different methods for adding electrodes in the microstructure conduits.
- Fig. 7 illustrates cutting the angled surface at the implanted end.
- Fig. 8 is a flowchart of a method according to the invention.
- Fig. 9 shows a diagram illustrating that there is less tissue inflammation using an angled fiber tip compared to flat-cleaved implant.
- Fig. 1 shows the fiber shank 5 of the neural implant 1.
- the optical waveguide 7 comprises a core 10 surrounded by a cladding 11.
- the fiber shank further comprises a fiber tip 12 at an implanted end 20.
- the fiber tip comprises a flat angled surface 14; the angled surface is angled relative to the longitudinal direction 19 of the fiber shank.
- the core 10 emanates in the centre of the fiber tip 12.
- the core 10 comprises an outlet 10' in the angled surface 14 of the fiber tip.
- Fig. 2 shows in (a) the neural implant from the side with the location of the microstructure conduits 13 in the cladding 11 are illustrated with dashed lines, (b) shows the neural implant from the front, so the angled surface 14 of the fiber tip 12 can be viewed.
- Fig. 2b shows the angled surface 14 of the fiber tip 12 with the core 10 surrounded by the cladding 11, and the outlets 13' of the microstructure conduits 13.
- the outlets 13' of the microstructure conduits 13 are at different levels 25, so different microstructure conduits with outlets at different levels emanates at different depth into the tissue, which may be brain tissue.
- Fig. 3 shows the neural implant 1, comprising the fiber shank 5 and the adaptor 6, inserted in a brain 32 of a mouse 35.
- the implanted end 20 with the angled surface 14 is located in the brain of the mouse, while the proximal end is outside the skull of the mouse and is connected through the adaptor 6 to a light source 30 so the core is guiding light from the light source to the fiber tip.
- the microstructure conduits are connected through the adaptor 6 to an electrophysiology setup 31, where some conduits may hold electrodes and other conduits may be microfluidic channels.
- FIG. 3 An enlarged section of Fig. 3 shows the tip of the fiber shank and illustrates that the outlets 13' of the microstructure conduits emanate at different levels 25 of the angled surface 14 of the implanted end 20.
- Fig. 4a and 4b show the difference between using a circular or a square core in the fiber shank.
- Fig. 4a and 4b show the light distribution profile at the output end of the 30° tip angle fiber with circular and square cores, respectively.
- the intensity has been normalized. Clearly, the light intensity is much more evenly distributed using a square core. When using a circular core, the light intensity is highest in the center of the circular core, whereas using a square core, the light intensity is evenly distributed all over the square core.
- Fig. 5a illustrates a method for manufacturing the fiber shank for the neural implant.
- a square core of core material 51 is inserted in a structured tube of cladding material 52 creating a preform 53.
- Fig. 5b shows that the preform 53 is then heated by a furnace 54 and attached to a tractor 55, which draws a fiber 56 out of the preform.
- the fiber 56 maintains the same structure as the preform with a core, a cladding, and microstructure conduits.
- Fig. 6a and 6b show two different methods for adding electrodes in the microstructure conduits.
- Fig. 6a shows that the electrodes may be added during the drawing process by pulling metal wires 61 from a feeder 62 and inserting the metal wires in the preform.
- the tractor 55 is used for pulling the metal wires feeder 62 and the preform feeder 53 during the manufacturing process of the fiber shank.
- metal wires 61 which work as electrodes 63, may be inserted in the microstructure conduits 13 after the fiber shank 5 has been formed.
- Fig. 7 shows that after the fiber shank 5 has been formed, a blade 71 is used to cut the angled surface at the implanted end 20 so that the outlets 13' of the microstructure conduits 13 are at different levels.
- Fig. 8 illustrates the method of manufacturing the neural implant by providing (SI) core material for the core of the optical waveguide and providing (S2) cladding material for the cladding of the optical waveguide.
- the core material and the cladding material are used to form (S3) a preform where the core material is inserted into the cladding material so that basically the preform is formed with a core with a square cross-section surrounded by a tube-formed cladding material.
- the conduits are formed in the cladding material.
- the preform is scaled down (S4) by a thermal drawing method by loading the preform into a furnace and the preform is then drawn into a fiber by a tractor drawing the fiber so that the preform is stretched into a fiber of a desired size by varying the speed of the tractor.
- the method comprises cutting (S5) the fiber into a suitable length to form a fiber shank of a required length and finally adjusting (S6) the fiber tip to comprise an angled surface.
- the surface being angled relative to the longitudinal direction of the fiber shank.
- FIG. 9 shows a diagram with a comparison between the mean values for fluorescent intensity (arbitrary units) which is indication the degree of inflammation in the brain four weeks after the implantation.
- Fig. 9 is showing a control mean florescence intensity value 91, where the fluorescent intensity is measured where there is no implant, a mean florescence intensity value 92 for the fluorescent intensity measured using an angled implant of the invention, and a mean florescence intensity value 93 for the fluorescent intensity measured using an implant with a flat end face fiber.
- the mean florescence intensity measured for the flat end shows a higher intensity than the mean florescence intensity measured for the angled surface. This is an experimental verification that the implant with an angled surface causes less inflammation.
- the invention may relate to:
- the neural implant (1) comprises o a fiber shank (5), and o an adaptor (6), for setup connectorization and light source connectorization,
- the fiber shank comprises o a proximal end (21) connected to the adaptor, o an implanted end (20) for implantation into tissue, and o a fiber tip (12) at the implanted end, o an optical waveguide (7) for optical neuromodulation, o a plurality of conduits (13), and o electrodes (63) may be inserted into one, or more, of the plurality of conduits for electrical neuromodulation,
- the optical waveguide (7) comprises a core (10) and a cladding (11), adapted so that light is able to propagate along the length of the optical waveguide,
- the cladding (11) comprises a central hole (22), the core (10) is placed in the central hole and is going from the proximal end (21) to the fiber tip (12), and
- each conduit going from the proximal end (21) to the fiber tip (12); wherein the non-circular shape of the core (10) is arranged for providing a substantially uniform intensity distribution of light radiation from the core at the fiber tip (12); and wherein the fiber tip comprises an angled surface (14), the end (10') of the core and the end (13') of the plurality of conduits are exposed at the angled surface so that the plurality of conduits (13) emanates at two or more different levels (25), where each level comprises a different depth into the tissue.
- E5. The neural implant according to any of the embodiments E1-E4, wherein the cladding (11) surrounds the core (10) so that the optical waveguide (7) and electrodes (63) in the fiber tip (12) are in contact with tissue when implanted.
- E6. The neural implant according to any of the embodiments E1-E5, wherein the cladding (11) comprises microfluidic channels for drug delivery in photopharmacology.
- a method for manufacturing an angled fiber-based neural implant for neuromodulation in tissue wherein the neural implant (1) comprises o a fiber shank (5), and o an adaptor (6), for setup connectorization and light source connectorization,
- the fiber shank (5) comprises o a proximal end (21) connected to the adaptor, o an implanted end (20) for implantation into tissue, o a fiber tip (12) at the implanted end, o an optical waveguide (7) for optical neuromodulation;
- the optical waveguide comprises a core (10) and a cladding (11), adapted so that light is able to propagate along the length of the waveguide, wherein the method comprises:
- the method is performed so that the fiber shank (5) comprises an optical waveguide (7), the optical waveguide comprises
- a core (10) comprising a non-circular shape for providing a substantially uniform intensity distribution of light radiation from the core (10) at the fiber tip (12) of the fiber shank (5) when guiding light from a light source (30) at the proximal end (21), and
- cladding (11) comprising a central hole (22) for holding the core (10), and a plurality of conduits (13), electrodes (63) may be inserted into one, or more, of the plurality of conduits (13) for electrical neuromodulation,
- the optical waveguide is manufactured so that light is able to propagate in the core (10) of the optical waveguide (7) by the total internal reflection principle.
- a post-insertion method comprising exposing the conduits (13) in the cladding (11) followed by the insertion of the electrodes (63).
- E12 The method for manufacturing a neural implant according to any of the embodiments E10-E11, wherein the method further comprises adjusting the fiber tip (12) of the fiber shank (5) by mechanical cutting, focused ion beam cutting, chemical etching, and/or femtosecond laser micromachining of the fiber tip, so that the plurality of conduits (13) emanates at two, or more, different levels (25), where each level comprises a different depth into the tissue.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP24731399.2A EP4727644A1 (en) | 2023-06-16 | 2024-06-12 | Angled fiber-based neural implant for neuromodulation |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23386049 | 2023-06-16 | ||
| EP23386049.3 | 2023-06-16 | ||
| EP23194138.6 | 2023-08-30 | ||
| EP23194138 | 2023-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024256494A1 true WO2024256494A1 (en) | 2024-12-19 |
Family
ID=91431316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2024/066284 Ceased WO2024256494A1 (en) | 2023-06-16 | 2024-06-12 | Angled fiber-based neural implant for neuromodulation |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4727644A1 (en) |
| WO (1) | WO2024256494A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130030352A1 (en) * | 2011-07-25 | 2013-01-31 | Seymour John P | Neuromodulation transfection system with active fluid delivery |
| US20180296243A1 (en) * | 2014-12-23 | 2018-10-18 | The Regents Of The University Of California | Methods, Compositions, and Systems for Device Implantation |
-
2024
- 2024-06-12 WO PCT/EP2024/066284 patent/WO2024256494A1/en not_active Ceased
- 2024-06-12 EP EP24731399.2A patent/EP4727644A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130030352A1 (en) * | 2011-07-25 | 2013-01-31 | Seymour John P | Neuromodulation transfection system with active fluid delivery |
| US20180296243A1 (en) * | 2014-12-23 | 2018-10-18 | The Regents Of The University Of California | Methods, Compositions, and Systems for Device Implantation |
Non-Patent Citations (2)
| Title |
|---|
| KIRTI SHARMA ET AL: "Multifunctional optrode for opsin delivery, optical stimulation, and electrophysiological recordings in freely moving rats", JOURNAL OF NEURAL ENGINEERING, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 18, no. 6, 15 November 2021 (2021-11-15), pages 66013, XP020371731, ISSN: 1741-2552, [retrieved on 20211115], DOI: 10.1088/1741-2552/AC3206 * |
| NAN ZHENG ET AL: "Multifunctional fiber-based optoacoustic emitter for non-genetic bidirectional neural communication", ARXIV.ORG, CORNELL UNIVERSITY LIBRARY, 201 OLIN LIBRARY CORNELL UNIVERSITY ITHACA, NY 14853, 9 January 2023 (2023-01-09), XP091411462 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4727644A1 (en) | 2026-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Spatially expandable fiber-based probes as a multifunctional deep brain interface | |
| EP3192562B1 (en) | Devices for optical stimulation of target cells using an optical transmission element | |
| Park et al. | One-step optogenetics with multifunctional flexible polymer fibers | |
| KR101304338B1 (en) | LCP-based electro-optrode neural interface and Method for fabricating the same | |
| US20200229704A1 (en) | Optoelectronic device to write-in and read-out activity in brain circuits | |
| Sileo et al. | Tapered fibers combined with a multi-electrode array for optogenetics in mouse medial prefrontal cortex | |
| US20150032190A1 (en) | Methods and apparatus for omnidirectional tissue illumination | |
| US10398293B2 (en) | Optogenetic tool for multiple and independently addressing of patterned optical windows | |
| Ward et al. | Electro-optical mechanically flexible coaxial microprobes for minimally invasive interfacing with intrinsic neural circuits | |
| Jiang et al. | Inhibitory effect of 980-nm laser on neural activity of the rat’s cochlear nucleus | |
| WO2024256494A1 (en) | Angled fiber-based neural implant for neuromodulation | |
| Boutte et al. | Utah optrode array customization using stereotactic brain atlases and 3-D CAD modeling for optogenetic neocortical interrogation in small rodents and nonhuman primates | |
| Meneghetti et al. | Opsin-free optical neuromodulation and electrophysiology enabled by a soft monolithic infrared multifunctional neural interface | |
| Markos et al. | DTU DTU Library | |
| Goncalves et al. | Implantable neural microsystems in medical industry | |
| Oh et al. | Optic-fiber-based optogenetic stimulator with μLED and 3D-printed structures for brain stimulation | |
| Tamaki et al. | Neural probe with multiple optical stimulation in depth direction | |
| Sui | Multifunctional polymer optical fiber-based neural devices | |
| Sui et al. | Multimodal Layer‐Crossing Interrogation of Brain Circuits Enabled by Microfluidic Axialtrodes | |
| Abaya | Implantable light delivery interfaces for optical neural stimulation | |
| Boutte | Optical Neural Interfaces for Optogenetic Interrogation | |
| Gautam | Perspective Chapter: Optoelectronics | |
| Park | Multifunctional fiber-based neural interfaces | |
| Petrovic et al. | Microstructured electrodes on optical fibers for biomedical applications | |
| Liu et al. | Fabrication and characterization of ultra-flexible optoelectrodes for chronic opto-electric neural interfaces |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24731399 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2024731399 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2024731399 Country of ref document: EP Effective date: 20260116 |
|
| ENP | Entry into the national phase |
Ref document number: 2024731399 Country of ref document: EP Effective date: 20260116 |
|
| ENP | Entry into the national phase |
Ref document number: 2024731399 Country of ref document: EP Effective date: 20260116 |
|
| ENP | Entry into the national phase |
Ref document number: 2024731399 Country of ref document: EP Effective date: 20260116 |
|
| WWP | Wipo information: published in national office |
Ref document number: 2024731399 Country of ref document: EP |